Skip to content

Can Combining Ayurveda Oil Therapy (shirodhara) with Hypnosis Help Reduce Anxiety? A Pilot Study

A Pilot Randomized Controlled Study to Evaluate the Efficacy of Hypno-Shirodhara for the Treatment of Anxiety Disorders - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112207
Enrollment
60
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health Health Condition 2: F411- Generalized anxiety disorder

Interventions

None listed

Sponsors

Nirvikalpa Integrated Therapy Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with Anxiety disorder (except phobia) according to DSM-5 Mild to moderate anxiety (HAM-A score 14-24) Able to understand English Those who are on stable pharmacotherapy in the past 6 weeks or those who are not willing to take pharmacotherapy Provide written informed consent

Exclusion criteria

Exclusion criteria: Active suicidal ideation or psychotic disorder Substance dependence (excluding nicotine and caffeine) Neurological or dermatological contraindications to the intervention Currently receiving structured psychotherapy for Anxiety Disorder Significant cognitive impairment that prevents participation in the study Severe anxiety (HAM-A score greater than or equal to 25) Current use of sleep medications (sedatives, hypnotics, or benzodiazepines for sleep) Dissociative symptoms as assessed by the MINI dissociative disorder module Personality disorders

Design outcomes

Primary

MeasureTime frame
Change in Hamilton Anxiety Rating Scale (HAM-A) scoreTimepoint: Baseline (Week 0) Full assessment battery Week 2 (Mid-intervention) HAM-A and ISI only Week 4 (Post-intervention) Full assessment battery plus Participant Experience Questionnaire Week 6 (Early follow-up) HAM-A and ISI only Week 8 (Follow-up) Full assessment battery Week 12 (Follow-up) Full assessment battery

Secondary

MeasureTime frame
Heart rate Variability (HRV), Sleep quality (ISI), quality of life (WHOQOL-BREF), subjective well-being (WHO-5), cognitive function (Stroop Test), and participant experienceTimepoint: Baseline (Week 0) Full assessment battery along with HRV Week 2 (Mid-intervention) HAM-A, HRV and ISI only Week 4 (Post-intervention) Full assessment battery including HRV plus participant Experience Questionnaire Week 6 (Early follow-up) HAM-A and ISI only Week 8 (Follow-up) Full assessment battery Week 12 (Follow-up) Full assessment battery; The wait-list control (tau arm) and hypnotherapy arm will receive hypnoshirodhara for 4 weeks post study and same secondary outcome assessment will be done at 4 week

Countries

India

Contacts

Public ContactDr Shyam Bhat

Director, Nirvikalpa Foundation

contact@nirvikalpafoundation.com9916799972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026